Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
250 participants
OBSERVATIONAL
2017-01-31
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breath Metabolomics in the Laboring Parturient
NCT04564196
Prospective Evaluation of Pathways for Preterm Birth
NCT05246579
Duration of Second Stage of Labor Wearing a Dental Occlusion Device
NCT00629369
Combined Spinal Epidural Urinary Retention
NCT01597791
Optimizing Postpartum Contraception in Women With Preterm Births
NCT01864629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study
We will be reviewing records of parturients seen at Johns Hopkins Hospital in the Center for Peripartum Optimization (CPO) clinic between January 2017 to January 2018
Seen in clinic
We will be doing a retrospective chart review of patients seen in the Center for Peripartum Optimization to look for:
1. Primary outcome variable.
\- Hospital length of stay
2. Secondary outcome variables.
* Number of admissions from outside hospitals
* Adverse outcomes
* Intensive Care Unit admissions
* Opioid use
* NICU admissions
* Patient satisfaction
* Cost of inpatient admission
* Cost of outpatient care
* Hospital readmissions rate
Control
A matched controlled group patients not seen at the CPO clinic
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Seen in clinic
We will be doing a retrospective chart review of patients seen in the Center for Peripartum Optimization to look for:
1. Primary outcome variable.
\- Hospital length of stay
2. Secondary outcome variables.
* Number of admissions from outside hospitals
* Adverse outcomes
* Intensive Care Unit admissions
* Opioid use
* NICU admissions
* Patient satisfaction
* Cost of inpatient admission
* Cost of outpatient care
* Hospital readmissions rate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Controlled group will include parturients with match high risk comorbidities or history of nonobstetric surgery during pregnancy who delivered at Johns Hopkins Hospital (JHH) during July 1, 2016 - Dec 31, 2016
* Patients with any one or more of these high risk comorbidities:
* Complex spine pathologies (Scoliosis, vertebral fusion, disc disease, spinal canal defects, neuropathies, and nerve disease, etc.)
* Neurological pathology (Cerebral ischemia, tumor, increased intracranial pressure, cerebral vascular disease, etc.)
* Cardiac disease (Congenital, valvular, pulmonary hypertension, cardiomyopathy, ischemic disease, arrhythmia, etc.)
* Pulmonary disease (History of pulmonary embolism, interstitial lung disease, severe asthma, cancer, etc.)
* Morbid Obesity (Obstructive Sleep Apnea, equipment considerations)
* Hematologic Disorders (Thrombophilias, coagulopathies, patients on anticoagulation)
* Cancer
* Abnormal placentation (Previa, accreta / increta / percreta)
* Anesthetic concerns (Airway abnormalities, history of adverse anesthetic reactions or experiences (i.e. recall, anaphylaxis))
* Fetal therapy patients requiring specialized management (Ex utero intrapartum treatment (EXIT), Fetoscopic endotracheal occlusion (FETO), Twin-to-twin transfusion syndrome (TTTS), Percutaneous Umbilical Blood Sampling (PUBS), etc.)
* Chronic Pain
* Records of patients seen in CPO clinic that did not deliver at our institution
Exclusion Criteria
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamie D Murphy, MD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins Hospital
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00163559
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.